BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fusco N, Bosari S. HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists. World J Gastroenterol 2016; 22(35): 7926-7937 [PMID: 27672288 DOI: 10.3748/wjg.v22.i35.7926]
URL: https://www.wjgnet.com/1007-9327/full/v22/i35/7926.htm
Number Citing Articles
1
Hong-Da Pan, Yi-Fan Peng, Gang Xiao, Jin Gu. High levels of serum platelet-derived growth factor-AA and human epidermal growth factor receptor-2 are predictors of colorectal cancer liver metastasisWorld Journal of Gastroenterology 2017; 23(7): 1233-1240 doi: 10.3748/wjg.v23.i7.1233
2
Csongor G. Lengyel, Baker Habeeb, Shah Z. Khan, Khalid El Bairi, Sara C. Altuna, Sadaqat Hussain, Syed Ayub Mazher, Dario Trapani, Angelica Petrillo. Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision MedicineGastrointestinal Disorders 2020; 3(1): 1 doi: 10.3390/gidisord3010001
3
Masakazu Fujimoto, Ibu Matsuzaki, Masaru Nishino, Yoshifumi Iwahashi, Kenji Warigaya, Fumiyoshi Kojima, Kazuo Ono, Shin-Ichi Murata. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological typesJournal of Clinical Pathology 2018; 71(7): 600 doi: 10.1136/jclinpath-2017-204928
4
Yujing Xuan, Yuqiao Sheng, Daiqun Zhang, Kai Zhang, Zhen Zhang, Yu Ping, Shumin Wang, Xiaojuan Shi, Jingyao Lian, Kangdong Liu, Yi Zhang, Feng Li. Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse modelsTranslational Oncology 2021; 14(8): 101138 doi: 10.1016/j.tranon.2021.101138
5
Madison Sherman, Karolina Gaebe, Alyssa Y. Li, Steven Habbous, Arjun Sahgal, Michael J. Raphael, Anders W. Erickson, Sunit Das. Erythroblastic oncogene B-2 status and intracranial metastatic disease in patients with gastrointestinal cancer: a systematic reviewJournal of Neuro-Oncology 2022; 160(3): 735 doi: 10.1007/s11060-022-04195-1
6
Samuel Navarro, Miriam Cuatrecasas, Javier Hernández-Losa, Stefania Landolfi, Eva Musulén, Santiago Ramón y Cajal, Rocío García-Carbonero, Jesús García-Foncillas, Pedro Pérez-Segura, Ramón Salazar, Ruth Vera, Pilar García-Alfonso. Actualización de la recomendación para la determinación de biomarcadores en el carcinoma colorrectal. Consenso Nacional de la Sociedad Española de Oncología Médica y de la Sociedad Española de Anatomía PatológicaRevista Española de Patología 2021; 54(1): 41 doi: 10.1016/j.patol.2020.07.004
7
Gianluca Lopez, Francesca Boggio, Stefano Ferrero, Nicola Fusco, Alessandro Del Gobbo. Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal CarcinomaInternational Journal of Molecular Sciences 2018; 19(10): 3014 doi: 10.3390/ijms19103014
8
Cindy Neuzillet, Pascal Artru, Eric Assenat, Julien Edeline, Xavier Adhoute, Jean-Christophe Sabourin, Anthony Turpin, Romain Coriat, David Malka. Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French PerspectiveTargeted Oncology 2023; 18(1): 51 doi: 10.1007/s11523-022-00942-6
9
Haowen Tang, Wenping Lu, Bingmin Li, Chonghui Li, Yinzhe Xu, Jiahong Dong. Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysisOncotarget 2017; 8(22): 36857 doi: 10.18632/oncotarget.16143
10
Mariia Ivanova, Francesca Maria Porta, Marianna D’Ercole, Carlo Pescia, Elham Sajjadi, Giulia Cursano, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis, Elena Guerini-Rocco, Giuseppe Curigliano, Giuseppe Viale, Nicola Fusco. Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancerVirchows Archiv 2024; 484(1): 3 doi: 10.1007/s00428-023-03656-w
11
Jean-Christophe Currie, Michel Demeule, Cyndia Charfi, Alain Zgheib, Alain Larocque, Bogdan Alexandru Danalache, Amira Ouanouki, Richard Béliveau, Christian Marsolais, Borhane Annabi. The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial CancersCancers 2022; 14(8): 1877 doi: 10.3390/cancers14081877
12
Shijie Sheng, M. Margarida Bernardo, Sijana H. Dzinic, Kang Chen, Elisabeth I. Heath, Wael A. Sakr. Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature reviewCancer and Metastasis Reviews 2018; 37(4): 655 doi: 10.1007/s10555-018-9767-4
13
Mariia Ivanova, Konstantinos Venetis, Elena Guerini-Rocco, Luca Bottiglieri, Mauro Giuseppe Mastropasqua, Ornella Garrone, Nicola Fusco, Michele Ghidini. HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic SchemesLife 2022; 12(9): 1403 doi: 10.3390/life12091403
14
Mariia Ivanova, Elham Sajjadi, Lorenzo Zattoni, Nicola Fusco. Hereditary Gastric and Breast Cancer Syndrome2023; : 149 doi: 10.1007/978-3-031-21317-5_10
15
Anna D. Wagner, Berna C. Özdemir, Josef Rüschoff. Human epidermal growth factor receptor 2-positive digestive tumorsCurrent Opinion in Oncology 2019; 31(4): 354 doi: 10.1097/CCO.0000000000000544
16
Gianluca Lopez, Jole Costanza, Matteo Colleoni, Laura Fontana, Stefano Ferrero, Monica Miozzo, Nicola Fusco. Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative TumorsInternational Journal of Molecular Sciences 2019; 20(3): 510 doi: 10.3390/ijms20030510
17
Gianluca Lopez, Konstantinos Venetis, Elham Sajjadi, Nicola Fusco. Mismatch Repair System Genomic Scars in Gastroesophageal Cancers: Biology and Clinical TestingGastrointestinal Disorders 2020; 2(4): 341 doi: 10.3390/gidisord2040031
18
Fabio Pagni, Elena Guerini-Rocco, Anne Maria Schultheis, Giulia Grazia, Erika Rijavec, Michele Ghidini, Gianluca Lopez, Konstantinos Venetis, Giorgio Alberto Croci, Umberto Malapelle, Nicola Fusco. Targeting Immune-Related Biological Processes in Solid Tumors: We do Need BiomarkersInternational Journal of Molecular Sciences 2019; 20(21): 5452 doi: 10.3390/ijms20215452
19
S.T. Kim, K.C. Banks, E. Pectasides, S.Y. Kim, K. Kim, R.B. Lanman, A. Talasaz, J. An, M.G. Choi, J.H. Lee, T.S. Sohn, J.M. Bae, S. Kim, S.H. Park, J.O. Park, Y.S. Park, H.Y. Lim, N.K.D. Kim, W. Park, H. Lee, A.J. Bass, K. Kim, W.K. Kang, J. Lee. Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patientsAnnals of Oncology 2018; 29(4): 1037 doi: 10.1093/annonc/mdy034
20
Antonio Ieni, Roberta Cardia, Cristina Pizzimenti, Pio Zeppa, Giovanni Tuccari. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different MethodologiesJournal of Personalized Medicine 2020; 10(1): 10 doi: 10.3390/jpm10010010
21
P. García-Alfonso, R. García-Carbonero, J. García-Foncillas, P. Pérez-Segura, R. Salazar, R. Vera, S. Ramón y Cajal, J. Hernández-Losa, S. Landolfi, E. Musulén, M. Cuatrecasas, S. Navarro. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of PathologyClinical and Translational Oncology 2020; 22(11): 1976 doi: 10.1007/s12094-020-02357-z
22
Maria Diab, Asfar Azmi, Ramzi Mohammad, Philip A. Philip. Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challengesExpert Opinion on Pharmacotherapy 2019; 20(5): 535 doi: 10.1080/14656566.2018.1561869
23
Massimiliano Salati, Konstantinos Venetis, Matteo Fassan, Umberto Malapelle, Fabio Pagni, Elham Sajjadi, Nicola Fusco, Michele Ghidini. ctDNA Analysis in the Personalized Clinical Management of Gastroesophageal Adenocarcinoma: Turning Hope Into RealityFuture Oncology 2021; 17(33): 4607 doi: 10.2217/fon-2021-0228
24
Konstantinos Venetis, Marco Invernizzi, Elham Sajjadi, Giuseppe Curigliano, Nicola Fusco. Cellular immunotherapy in breast cancer: The quest for consistent biomarkersCancer Treatment Reviews 2020; 90: 102089 doi: 10.1016/j.ctrv.2020.102089
25
Elsa N. Garza Treviño, Adriana G. Quiroz Reyes, Juan Antonio Rojas Murillo, David A de la Garza Kalife, Paulina Delgado Gonzalez, Jose F. Islas, Ana Esther Estrada Rodriguez, Carlos A. Gonzalez Villarreal. Cell Therapy as Target Therapy against Colon Cancer Stem CellsInternational Journal of Molecular Sciences 2023; 24(9): 8163 doi: 10.3390/ijms24098163
26
Keita Kai, Yukie Yoda, Atsushi Kawaguchi, Akimichi Minesaki, Hironori Iwasaki, Shinichi Aishima, Hirokazu Noshiro. Formalin fixation on HER-2 and PD-L1 expression in gastric cancer: A pilot analysis using the same surgical specimens with different fixation timesWorld Journal of Clinical Cases 2019; 7(4): 419-430 doi: 10.12998/wjcc.v7.i4.419
27
Li-Fei Sun, Kun Yang, Yi-Gao Wang, Yu-Xin Liu, Pei-Xian Hou, Zheng-Hao Lu, Xiao-Long Chen, Wei-Han Zhang, Zong-Guang Zhou, Xian-Ming Mo, Jian-Kun Hu. The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem CellsFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01608
28
Pragya Jain, Surbhi Goyal, Geeta Chauhan, Kaushik Majumdar, Shahajad Ali, Puja Sakhuja, AnilK Agarwal. HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic targetIndian Journal of Pathology and Microbiology 2020; 63(2): 214 doi: 10.4103/IJPM.IJPM_664_19
29
Ayumi Saito, Hiroshi Yoshida, Tadaaki Nishikawa, Kan Yonemori. Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectivesWorld Journal of Clinical Oncology 2021; 12(10): 868-881 doi: 10.5306/wjco.v12.i10.868
30
Ioan Cătălin Bodea, Andra Ciocan, Florin Vasile Zaharie, Raluca Bodea, Florin Graur, Ștefan Ursu, Răzvan Alexandru Ciocan, Nadim Al Hajjar. HER2 Overexpression in Periampullary Tumors According to Anatomical and Histological Classification—A Systematic ReviewJournal of Personalized Medicine 2024; 14(5): 463 doi: 10.3390/jpm14050463
31
Dustin E. Bosch, Matthew M. Yeh, Paul E. Swanson. Gattuso's Differential Diagnosis in Surgical Pathology2022; : 405 doi: 10.1016/B978-0-323-66165-2.00007-7
32
Marco Invernizzi, Anna Michelotti, Marianna Noale, Gianluca Lopez, Letterio Runza, Massimo Giroda, Luca Despini, Concetta Blundo, Stefania Maggi, Donatella Gambini, Nicola Fusco. Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of TrastuzumabJournal of Clinical Medicine 2019; 8(2): 138 doi: 10.3390/jcm8020138
33
Lulu Rong, Bingzhi Wang, Lei Guo, Xiuyun Liu, Bingning Wang, Jianming Ying, Liyan Xue, Ning Lu. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese populationDiagnostic Pathology 2020; 15(1) doi: 10.1186/s13000-020-00950-y
34
Davinder Singh, Divya Dheer, Abhilash Samykutty, Ravi Shankar. Antibody drug conjugates in gastrointestinal cancer: From lab to clinical developmentJournal of Controlled Release 2021; 340: 1 doi: 10.1016/j.jconrel.2021.10.006
35
Hayley Pye, Mohammed Adil Butt, Laura Funnell, Halla W. Reinert, Ignazio Puccio, Saif U. Rehman Khan, Savvas Saouros, Jared S. Marklew, Ioanna Stamati, Maryam Qurashi, Rehan Haidry, Vinay Sehgal, Dahmane Oukrif, Michael Gandy, Hayley C. Whitaker, Manuel Rodriguez-Justo, Marco Novelli, Rifat Hamoudi, Gokhan Yahioglu, Mahendra P. Deonarain, Laurence B. Lovat. Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expressionOncotarget 2018; 9(33): 22945 doi: 10.18632/oncotarget.25159
36
Konstantinos Venetis, Edoardo Crimini, Elham Sajjadi, Chiara Corti, Elena Guerini-Rocco, Giuseppe Viale, Giuseppe Curigliano, Carmen Criscitiello, Nicola Fusco. HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast CancerFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.834651
37
Aaditya Srivant Geddam, Areeb Lutfi, Maaz Khan Afghan, Brian M. Currie, Russell Rosenblatt, Arturo B. Ramirez, Erin G. Bayer, Erika Hissong, Pashtoon Murtaza Kasi. Liquid biopsy kinetics and detection of ERBB2 amplification/HER2-positivity in refractory hepatocellular carcinomaThe Journal of Liquid Biopsy 2023; 2: 100009 doi: 10.1016/j.jlb.2023.100009
38
Chiara Pedicone, Shea T. Meyer, John D. Chisholm, William G. Kerr. Targeting SHIP1 and SHIP2 in CancerCancers 2021; 13(4): 890 doi: 10.3390/cancers13040890
39
Han-Qi Wang, Ruxing Fu, Qi-Wen Man, Guang Yang, Bing Liu, Lin-Lin Bu. Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell CarcinomaJournal of Clinical Medicine 2023; 12(6): 2173 doi: 10.3390/jcm12062173